Treatment with Ziprasidone for schizophrenia patients with OCD

Alzbeta Juven-Wetzler, Leah Fostick, Shlomit Cwikel-Hamzany, Evgenya Balaban, Joseph Zohar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Comorbidity of obsessive-compulsive disorder (OCD) has been observed in about 15% of schizophrenic patients and has been associated with poor prognosis. Therefore, there is a need for specific treatment options for these patients (schizo-obsessive, ScOCD).This is an open, prospective study, aiming to test the efficacy of Ziprasidone (80-200. mg/d) in ScOCD patients and comparing the response to the treatment between stable schizophrenic (N=16) and stable ScOCD (N=29) patients. Treatment effect with Ziprasidone was different in schizophrenic patients when stratified based on OCD comorbidity. Overall, the effect on OCD symptoms (as measured by the Yale Brown Obsessive Compulsive Scale, YBOCS) was found to be bimodal-either no response or exacerbation (for 45% of the patients, n=13) or significant improvement of symptoms (55%, n=16). Those who improved in OCD symptoms, improved also in negative and general schizophrenia symptoms, while ScOCD-unimproved group worsened in all symptoms. Whereas schizophrenic patients without OCD responded in a modest Gaussian distribution, they improved in schizophrenia negative symptoms and in general anxiety. This data suggests that schizo-obsessive disorder is a distinct and complex condition with more than one underlying pathogenesis. Definition of these ScOCD subgroups defined by their response to Ziprasidone might contribute to personalized medicine within the OCD-schizophrenia spectrum. Moreover, this finding suggests that ScOCD may be considered as a special schizophrenic subtype and its inclusion in schizophrenia treatment studies need to be further explored due to its divergent response.

Original languageEnglish
Pages (from-to)1454-1462
Number of pages9
JournalEuropean Neuropsychopharmacology
Issue number9
StatePublished - Sep 2014
Externally publishedYes


FundersFunder number


    • OCD
    • Personalized medicine
    • Schizophrenia
    • Ziprasidone


    Dive into the research topics of 'Treatment with Ziprasidone for schizophrenia patients with OCD'. Together they form a unique fingerprint.

    Cite this